Literature DB >> 18060458

Mammary cancer susceptibility: human genes and rodent models.

Claude Szpirer1, Josiane Szpirer.   

Abstract

Breast cancer is a complex disease, showing a strong genetic component. Several human susceptibility genes have been identified, especially in the last few months. Most of these genes are low-penetrance genes and it is clear that numerous other susceptibility genes remain to be identified. The function of several susceptibility genes indicates that one critical biological pathway is the DNA damage response. However, other pathways certainly play a significant role in breast cancer susceptibility. Rodent models of breast cancer are useful models in two respects. They can help identify new mammary susceptibility genes by taking advantage of the very divergent susceptibilities exhibited by different mouse or rat strains and carrying out relevant genetic analyses. They also provide investigators with experimental systems that can help decipher the mechanism(s) of resistance to mammary cancer. Recent genetic and biological results obtained with mouse and especially with rat strains indicate that (1) numerous quantitative trait loci control mammary cancer susceptibility or resistance, with distinct loci acting in different strains, and (2) distinct resistance mechanisms operate in different rat resistant strains, precocious mammary differentiation being one of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060458     DOI: 10.1007/s00335-007-9073-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  157 in total

1.  Strain differences in response to estrone and the induction of mammary gland, adrenal, and bladder cancer in rats.

Authors:  W F DUNNING; M R CURTIS; A SEGALOFF
Journal:  Cancer Res       Date:  1953-02       Impact factor: 12.701

2.  Characterizing a rat Brca2 knockout model.

Authors:  M S Cotroneo; J D Haag; Y Zan; C C Lopez; P Thuwajit; G V Petukhova; R D Camerini-Otero; A Gendron-Fitzpatrick; A E Griep; C J Murphy; R R Dubielzig; M N Gould
Journal:  Oncogene       Date:  2006-09-11       Impact factor: 9.867

3.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

4.  A recurrent mutation in PALB2 in Finnish cancer families.

Authors:  Hannele Erkko; Bing Xia; Jenni Nikkilä; Johanna Schleutker; Kirsi Syrjäkoski; Arto Mannermaa; Anne Kallioniemi; Katri Pylkäs; Sanna-Maria Karppinen; Katrin Rapakko; Alexander Miron; Qing Sheng; Guilan Li; Henna Mattila; Daphne W Bell; Daniel A Haber; Mervi Grip; Mervi Reiman; Arja Jukkola-Vuorinen; Aki Mustonen; Juha Kere; Lauri A Aaltonen; Veli-Matti Kosma; Vesa Kataja; Ylermi Soini; Ronny I Drapkin; David M Livingston; Robert Winqvist
Journal:  Nature       Date:  2007-02-07       Impact factor: 49.962

5.  A mammary cancer suppressor gene and its site of action in the rat.

Authors:  J T Isaacs
Journal:  Cancer Res       Date:  1991-03-15       Impact factor: 12.701

6.  Mammary cancer resistance and precocious mammary differentiation in the WKY rat: identification of 2 quantitative trait loci.

Authors:  Virginie Lella; Daniel Stieber; Michèle Rivière; Josiane Szpirer; Claude Szpirer
Journal:  Int J Cancer       Date:  2007-10-15       Impact factor: 7.396

7.  Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.

Authors:  R J Coffey; K S Meise; Y Matsui; B L Hogan; P J Dempsey; S A Halter
Journal:  Cancer Res       Date:  1994-04-01       Impact factor: 12.701

8.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression.

Authors:  T Lifsted; T Le Voyer; M Williams; W Muller; A Klein-Szanto; K H Buetow; K W Hunter
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

9.  Inheritance of a genetic factor from the Copenhagen rat and the suppression of chemically induced mammary adenocarcinogenesis.

Authors:  J T Isaacs
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

10.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

View more
  12 in total

1.  Rat Mcs1b is concordant to the genome-wide association-identified breast cancer risk locus at human 5q11.2 and MIER3 is a candidate cancer susceptibility gene.

Authors:  Aaron D denDekker; Xin Xu; M Derek Vaughn; Aaron H Puckett; Louis L Gardner; Courtney J Lambring; Lucas Deschenes; David J Samuelson
Journal:  Cancer Res       Date:  2012-09-19       Impact factor: 12.701

2.  Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.

Authors:  Anneke C Blackburn; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-08       Impact factor: 2.673

Review 3.  Induced mammary cancer in rat models: pathogenesis, genetics, and relevance to female breast cancer.

Authors:  James L Miller; Arianna P Bartlett; Rebecca M Harman; Prabin Dhangada Majhi; D Joseph Jerry; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-07-29       Impact factor: 2.698

Review 4.  Mouse modifier genes in mammary tumorigenesis and metastasis.

Authors:  Scott F Winter; Kent W Hunter
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

5.  Contrasting epistatic interactions between rat quantitative trait loci controlling mammary cancer development.

Authors:  Géraldine Piessevaux; Virginie Lella; Michèle Rivière; Daniel Stieber; Pierre Drèze; Josiane Szpirer; Claude Szpirer
Journal:  Mamm Genome       Date:  2008-12-04       Impact factor: 2.957

6.  Differences in the Rate of in Situ Mammary Gland Development and Other Developmental Endpoints in Three Strains of Female Rat Commonly Used in Mammary Carcinogenesis Studies: Implications for Timing of Carcinogen Exposure.

Authors:  Jason P Stanko; Grace E Kissling; Vesna A Chappell; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2016-09-09       Impact factor: 1.902

7.  BAC CGH-array identified specific small-scale genomic imbalances in diploid DMBA-induced rat mammary tumors.

Authors:  Emma Samuelson; Sara Karlsson; Karolina Partheen; Staffan Nilsson; Claude Szpirer; Afrouz Behboudi
Journal:  BMC Cancer       Date:  2012-08-15       Impact factor: 4.430

8.  siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Authors:  M Böhringer; K Obermeier; N Griner; D Waldraff; E Dickinson; K Eirich; D Schindler; M Hagen; D J Jerry; L Wiesmüller
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

9.  The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.

Authors:  Bart M G Smits; Jill D Haag; Anna I Rissman; Deepak Sharma; Ann Tran; Alexi A Schoenborn; Rachael C Baird; Dan S Peiffer; David Q Leinweber; Matthew J Muelbl; Amanda L Meilahn; Mark R Eichelberg; Ning Leng; Christina Kendziorski; Manorama C John; Patricia A Powers; Caroline M Alexander; Michael N Gould
Journal:  PLoS Genet       Date:  2013-06-13       Impact factor: 5.917

10.  Multiple susceptibility loci for radiation-induced mammary tumorigenesis in F2[Dahl S x R]-intercross rats.

Authors:  Victoria L Herrera; Lorenz R Ponce; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.